Top Markets
Coin of the day
Anew Medical, Inc. Anew Medical, Inc.

Anew Medical, Inc.

WENA
Rang in aandelen #33463
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
Aandeelprijs
$0.5099
Laatst gesynchroniseerd: 2024-10-15
Marktkapitalisatie
$7.60M
Verandering (1 dag)
2.02%
Verandering (1 jaar)
0.00%
Land
US
Handel Anew Medical, Inc. (WENA)

Categorie

EPS voor Anew Medical, Inc. (WENA)
EPS per June 2024 TTM: $0.00
Volgens de laatste financiële rapporten en de aandelenkoers van Anew Medical, Inc. is de huidige EPS van het bedrijf (TTM) $0.00. Eind 2022 had het bedrijf een EPS van $0.08, een stijging ten opzichte van de EPS van 2021 die $-0.09 bedroeg.
EPS-geschiedenis van Anew Medical, Inc. van 2021 tot 2026
EPS aan het einde van elk jaar
Jaar EPS Wijzigen
2026 (TTM) 0.00 -102.64%
2023 $0.14 69.29%
2022 $0.08 -196.73%
2021 $-0.09 0.00%
EPS van vergelijkbare bedrijven of concurrenten
Bedrijf EPS EPS-verschil Land
$17.32 -468,208.11%
US
$27.74 -749,829.73%
NL
- -
CH
- -
KR
$13.70 -370,372.97%
BE